Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Marrow Neoplasms × Hydroxyurea × Myeloid × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia, Myeloid, Chronic-Phase 7 Leukemia 7 Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Myeloproliferative Disorders 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Primary Myelofibrosis 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Congenital Abnormalities 2 Thrombosis 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Polycythemia 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Bone Marrow Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

ruxolitinib 1 Stem Cell Transplantation 1 SCIO-469 1 Hydroxyurea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting

Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡